| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | KIR2DL5B KIR2DS2 KIR2DL5A TNFAIP3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 CBLB SOS1 | 8.69e-06 | 615 | 59 | 10 | GO:0002764 |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-threonine phosphorylation | 4.31e-05 | 24 | 59 | 3 | GO:0010801 | |
| Domain | ig | 2.95e-05 | 190 | 59 | 6 | PF00047 | |
| Domain | Immunoglobulin | 2.95e-05 | 190 | 59 | 6 | IPR013151 | |
| Domain | FAM47 | 5.86e-05 | 4 | 59 | 2 | PF14642 | |
| Domain | FAM47 | 5.86e-05 | 4 | 59 | 2 | IPR032743 | |
| Domain | - | FNDC1 ANOS1 HLA-F KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 | 2.18e-04 | 663 | 59 | 9 | 2.60.40.10 |
| Domain | Ig-like_fold | FNDC1 ANOS1 HLA-F KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 | 3.46e-04 | 706 | 59 | 9 | IPR013783 |
| Domain | IG_LIKE | 8.70e-04 | 491 | 59 | 7 | PS50835 | |
| Domain | Ig-like_dom | 1.00e-03 | 503 | 59 | 7 | IPR007110 | |
| Domain | Post-SET_dom | 1.14e-03 | 16 | 59 | 2 | IPR003616 | |
| Domain | PostSET | 1.14e-03 | 16 | 59 | 2 | SM00508 | |
| Domain | POST_SET | 1.14e-03 | 16 | 59 | 2 | PS50868 | |
| Domain | IG | 2.08e-03 | 421 | 59 | 6 | SM00409 | |
| Domain | Ig_sub | 2.08e-03 | 421 | 59 | 6 | IPR003599 | |
| Domain | GDS_CDC24_CS | 6.74e-03 | 39 | 59 | 2 | IPR001331 | |
| Domain | SET | 7.43e-03 | 41 | 59 | 2 | PF00856 | |
| Domain | SET | 9.29e-03 | 46 | 59 | 2 | SM00317 | |
| Domain | PDZ | 1.01e-02 | 141 | 59 | 3 | PF00595 | |
| Domain | SET_dom | 1.09e-02 | 50 | 59 | 2 | IPR001214 | |
| Domain | SET | 1.09e-02 | 50 | 59 | 2 | PS50280 | |
| Domain | PDZ | 1.15e-02 | 148 | 59 | 3 | SM00228 | |
| Domain | - | 1.19e-02 | 150 | 59 | 3 | 2.30.42.10 | |
| Domain | PDZ | 1.21e-02 | 151 | 59 | 3 | PS50106 | |
| Domain | PDZ | 1.23e-02 | 152 | 59 | 3 | IPR001478 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 1.43e-07 | 41 | 43 | 5 | M13519 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 2.52e-07 | 88 | 43 | 6 | M16004 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 3.42e-06 | 137 | 43 | 6 | M5669 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 1.12e-05 | 46 | 43 | 4 | M27151 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 2.12e-05 | 54 | 43 | 4 | MM14871 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 2.68e-04 | 190 | 43 | 5 | M8240 | |
| Pubmed | 5.39e-17 | 13 | 60 | 7 | 19120281 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | 3.58e-16 | 16 | 60 | 7 | 16403292 | |
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | 6.07e-16 | 17 | 60 | 7 | 19218127 | |
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | 6.07e-16 | 17 | 60 | 7 | 20878400 | |
| Pubmed | 6.07e-16 | 17 | 60 | 7 | 20650299 | ||
| Pubmed | 6.07e-16 | 17 | 60 | 7 | 19450876 | ||
| Pubmed | 6.07e-16 | 17 | 60 | 7 | 19761533 | ||
| Pubmed | 9.92e-16 | 18 | 60 | 7 | 20200544 | ||
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | 2.41e-15 | 20 | 60 | 7 | 20193031 | |
| Pubmed | 5.29e-15 | 22 | 60 | 7 | 20492596 | ||
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | 9.35e-15 | 11 | 60 | 6 | 19664392 | |
| Pubmed | 1.29e-14 | 5 | 60 | 5 | 16112031 | ||
| Pubmed | 1.29e-14 | 5 | 60 | 5 | 18755860 | ||
| Pubmed | 1.87e-14 | 12 | 60 | 6 | 20371502 | ||
| Pubmed | 1.87e-14 | 12 | 60 | 6 | 19936734 | ||
| Pubmed | 3.46e-14 | 13 | 60 | 6 | 18687225 | ||
| Pubmed | 6.05e-14 | 14 | 60 | 6 | 19875891 | ||
| Pubmed | Multiple sclerosis associates with LILRA3 deletion in Spanish patients. | 6.05e-14 | 14 | 60 | 6 | 19421224 | |
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | 6.05e-14 | 14 | 60 | 6 | 15896204 | |
| Pubmed | 6.05e-14 | 14 | 60 | 6 | 19489269 | ||
| Pubmed | 1.01e-13 | 15 | 60 | 6 | 20082646 | ||
| Pubmed | 1.01e-13 | 15 | 60 | 6 | 19926642 | ||
| Pubmed | 1.01e-13 | 15 | 60 | 6 | 19850842 | ||
| Pubmed | Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. | 1.01e-13 | 15 | 60 | 6 | 20207982 | |
| Pubmed | 1.01e-13 | 15 | 60 | 6 | 19493232 | ||
| Pubmed | 1.01e-13 | 15 | 60 | 6 | 20356536 | ||
| Pubmed | 1.01e-13 | 15 | 60 | 6 | 20643584 | ||
| Pubmed | KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. | 1.01e-13 | 15 | 60 | 6 | 17498266 | |
| Pubmed | 1.01e-13 | 15 | 60 | 6 | 19326408 | ||
| Pubmed | 1.61e-13 | 16 | 60 | 6 | 19897003 | ||
| Pubmed | 1.61e-13 | 16 | 60 | 6 | 19000141 | ||
| Pubmed | 1.61e-13 | 16 | 60 | 6 | 20670355 | ||
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | 1.61e-13 | 16 | 60 | 6 | 19527230 | |
| Pubmed | 1.61e-13 | 16 | 60 | 6 | 20652381 | ||
| Pubmed | 1.61e-13 | 16 | 60 | 6 | 18668235 | ||
| Pubmed | 1.61e-13 | 16 | 60 | 6 | 19279038 | ||
| Pubmed | 1.61e-13 | 16 | 60 | 6 | 17868255 | ||
| Pubmed | 1.61e-13 | 16 | 60 | 6 | 18643961 | ||
| Pubmed | 1.61e-13 | 16 | 60 | 6 | 19309280 | ||
| Pubmed | 1.61e-13 | 16 | 60 | 6 | 20331834 | ||
| Pubmed | 1.61e-13 | 16 | 60 | 6 | 20210919 | ||
| Pubmed | 2.05e-13 | 35 | 60 | 7 | 19683555 | ||
| Pubmed | 2.49e-13 | 17 | 60 | 6 | 20173784 | ||
| Pubmed | 2.49e-13 | 17 | 60 | 6 | 20173792 | ||
| Pubmed | 2.49e-13 | 17 | 60 | 6 | 20483367 | ||
| Pubmed | 2.49e-13 | 17 | 60 | 6 | 19968064 | ||
| Pubmed | 2.49e-13 | 17 | 60 | 6 | 19169284 | ||
| Pubmed | Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. | 2.70e-13 | 7 | 60 | 5 | 11169255 | |
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | 3.72e-13 | 18 | 60 | 6 | 19630074 | |
| Pubmed | 3.72e-13 | 18 | 60 | 6 | 20519398 | ||
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | 3.72e-13 | 18 | 60 | 6 | 19046302 | |
| Pubmed | 3.72e-13 | 18 | 60 | 6 | 19846535 | ||
| Pubmed | 3.72e-13 | 18 | 60 | 6 | 20580654 | ||
| Pubmed | KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. | 5.43e-13 | 19 | 60 | 6 | 18571006 | |
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | 5.43e-13 | 19 | 60 | 6 | 18778326 | |
| Pubmed | 5.43e-13 | 19 | 60 | 6 | 20600442 | ||
| Pubmed | 5.43e-13 | 19 | 60 | 6 | 18848853 | ||
| Pubmed | 7.19e-13 | 8 | 60 | 5 | 18681957 | ||
| Pubmed | 7.75e-13 | 20 | 60 | 6 | 20426625 | ||
| Pubmed | 1.08e-12 | 21 | 60 | 6 | 19861144 | ||
| Pubmed | 3.23e-12 | 10 | 60 | 5 | 12559621 | ||
| Pubmed | 5.91e-12 | 11 | 60 | 5 | 18830515 | ||
| Pubmed | 8.00e-12 | 4 | 60 | 4 | 26542066 | ||
| Pubmed | Immunogenetic characteristics of patients with autoimmune gastritis. | 9.39e-12 | 29 | 60 | 6 | 20082482 | |
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | 1.01e-11 | 12 | 60 | 5 | 19181658 | |
| Pubmed | 1.01e-11 | 12 | 60 | 5 | 20137308 | ||
| Pubmed | 1.64e-11 | 13 | 60 | 5 | 19934297 | ||
| Pubmed | 2.55e-11 | 14 | 60 | 5 | 18945962 | ||
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 12121272 | ||
| Pubmed | Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual. | 4.00e-11 | 5 | 60 | 4 | 10424431 | |
| Pubmed | 7.85e-11 | 17 | 60 | 5 | 19032228 | ||
| Pubmed | 1.09e-10 | 18 | 60 | 5 | 20210918 | ||
| Pubmed | 1.20e-10 | 6 | 60 | 4 | 17882223 | ||
| Pubmed | KIR haplotype content at the allele level in 77 Northern Irish families. | 5.57e-10 | 8 | 60 | 4 | 17200871 | |
| Pubmed | 1.00e-09 | 9 | 60 | 4 | 7749980 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | 3.92e-09 | 12 | 60 | 4 | 17490516 | |
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 29549293 | ||
| Pubmed | The extended human leukocyte receptor complex: diverse ways of modulating immune responses. | 4.88e-09 | 3 | 60 | 3 | 18759923 | |
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 30696053 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 17092261 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 19877200 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 15879158 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 15140215 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 26888639 | ||
| Pubmed | Promoter variants of KIR2DL5 add to diversity and may impact gene expression. | 4.88e-09 | 3 | 60 | 3 | 18461314 | |
| Pubmed | Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis. | 4.88e-09 | 3 | 60 | 3 | 22960345 | |
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 23380384 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 26430804 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 19549382 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 18292496 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 20056126 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 16571411 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 16929347 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 18091530 | ||
| Pubmed | [Analysis of HLA-Cw, KIR2D genetic variations in 2 Chinese populations]. | 1.95e-08 | 4 | 60 | 3 | 18543232 | |
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 25037176 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 18269867 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 18498296 | ||
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 16698429 | ||
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 7716543 | ||
| Interaction | KIR3DL1 interactions | 6.68e-06 | 13 | 59 | 3 | int:KIR3DL1 | |
| Interaction | KIR2DL2 interactions | 6.68e-06 | 13 | 59 | 3 | int:KIR2DL2 | |
| Interaction | KIR2DS3 interactions | 2.62e-05 | 20 | 59 | 3 | int:KIR2DS3 | |
| Interaction | KIR3DP1 interactions | 5.04e-05 | 4 | 59 | 2 | int:KIR3DP1 | |
| Interaction | KIR2DS1 interactions | 5.04e-05 | 4 | 59 | 2 | int:KIR2DS1 | |
| Cytoband | 19q13.4 | 6.73e-08 | 79 | 60 | 5 | 19q13.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 9.10e-04 | 1192 | 60 | 7 | chr19q13 | |
| Cytoband | Xp21.1 | 9.17e-04 | 34 | 60 | 2 | Xp21.1 | |
| Cytoband | 10q21.3 | 9.17e-04 | 34 | 60 | 2 | 10q21.3 | |
| Cytoband | 2q11.2 | 4.05e-03 | 72 | 60 | 2 | 2q11.2 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 3.16e-15 | 18 | 38 | 7 | 620 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.56e-05 | 394 | 38 | 7 | 471 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.31e-03 | 34 | 38 | 2 | 487 | |
| GeneFamily | PDZ domain containing | 3.96e-03 | 152 | 38 | 3 | 1220 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.44e-03 | 181 | 38 | 3 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.48e-03 | 66 | 38 | 2 | 722 | |
| Coexpression | KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE | 1.30e-09 | 49 | 59 | 6 | M40909 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN | 3.20e-07 | 199 | 59 | 7 | M9885 | |
| Coexpression | GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN | 4.39e-06 | 190 | 59 | 6 | M4662 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 3.05e-06 | 179 | 56 | 5 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.40e-06 | 183 | 56 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-06 | 183 | 56 | 5 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.49e-06 | 184 | 56 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.49e-06 | 184 | 56 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 3.59e-06 | 185 | 56 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.59e-06 | 185 | 56 | 5 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.68e-06 | 186 | 56 | 5 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.78e-06 | 187 | 56 | 5 | 173f029dcf32af008f517912f6d110a33a9e98cf | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.88e-06 | 188 | 56 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-06 | 188 | 56 | 5 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | AT1-AT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.88e-06 | 188 | 56 | 5 | be710bc957118cf426dd71c2d57e6f1b41c9a467 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.98e-06 | 189 | 56 | 5 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 4.87e-06 | 197 | 56 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.00e-06 | 198 | 56 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.00e-06 | 198 | 56 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.25e-05 | 144 | 56 | 4 | 7c471e332f87d60f4dbed01f3e66bf39995218d0 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 4.44e-05 | 156 | 56 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 367C-Lymphocytic-ILC|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.90e-05 | 160 | 56 | 4 | f70ec054b6d51c1565e4a257cbe3c9537c0eb09f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-05 | 161 | 56 | 4 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-05 | 161 | 56 | 4 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.27e-05 | 163 | 56 | 4 | 11cc18f36604d9a5f4e7fb8626a8f0fb141da5e1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.92e-05 | 168 | 56 | 4 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 6.20e-05 | 170 | 56 | 4 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.34e-05 | 171 | 56 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.34e-05 | 171 | 56 | 4 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T|normal_Pleural_Fluid / Location, Cell class and cell subclass | 6.34e-05 | 171 | 56 | 4 | 6be81c20f4e962b414afcedfe478dd59c510d1e1 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 6.63e-05 | 173 | 56 | 4 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 6.78e-05 | 174 | 56 | 4 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.94e-05 | 175 | 56 | 4 | ba1befc4e5f0167452f9ceace39377d16136dfa9 | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 7.25e-05 | 177 | 56 | 4 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.25e-05 | 177 | 56 | 4 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.41e-05 | 178 | 56 | 4 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.57e-05 | 179 | 56 | 4 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-Megakaryocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.57e-05 | 179 | 56 | 4 | 8d9bad6507fac0926163807a0bda62a57e7660e3 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.57e-05 | 179 | 56 | 4 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.57e-05 | 179 | 56 | 4 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-NK_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.74e-05 | 180 | 56 | 4 | 512c005567ad9c78cc5cc83862fc1219bcf49f60 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.74e-05 | 180 | 56 | 4 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | AT1_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 7.74e-05 | 180 | 56 | 4 | ff4728782c3ec814ba071cc22b7894abdd9da837 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.90e-05 | 181 | 56 | 4 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 7.90e-05 | 181 | 56 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | PBMC-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 8.07e-05 | 182 | 56 | 4 | 4774066d0f9986abc3d13a2a3bc99ce4f1327ae0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.07e-05 | 182 | 56 | 4 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.25e-05 | 183 | 56 | 4 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.25e-05 | 183 | 56 | 4 | 8746e6ecc6bf9e194cc9cdf9b07da63f0fcf8b5f | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 8.25e-05 | 183 | 56 | 4 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.25e-05 | 183 | 56 | 4 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.25e-05 | 183 | 56 | 4 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 8.25e-05 | 183 | 56 | 4 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.25e-05 | 183 | 56 | 4 | b902390614fe924d48511e4187b36a0b49b08f23 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.25e-05 | 183 | 56 | 4 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.42e-05 | 184 | 56 | 4 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 8.42e-05 | 184 | 56 | 4 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.60e-05 | 185 | 56 | 4 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.60e-05 | 185 | 56 | 4 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.60e-05 | 185 | 56 | 4 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.60e-05 | 185 | 56 | 4 | c985a4b184d382a79aaff07f81c0efede2c2d493 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.60e-05 | 185 | 56 | 4 | d0d0e000ebe1fc35a987930ceaf7e3369e0c694c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.60e-05 | 185 | 56 | 4 | 0ca99fcbd30c454bcdc2aa5265a0e4dba25666ea | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.60e-05 | 185 | 56 | 4 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.60e-05 | 185 | 56 | 4 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.60e-05 | 185 | 56 | 4 | 0f722ffcc3e78d5c6b1b79d31d00929801a993f1 | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.60e-05 | 185 | 56 | 4 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.60e-05 | 185 | 56 | 4 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.78e-05 | 186 | 56 | 4 | facc1bd8920003ad03d1893c32fc606d82b4d50a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.78e-05 | 186 | 56 | 4 | 885aed2472cead81d60c9f3a28c0ff10eb449592 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 8.78e-05 | 186 | 56 | 4 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.96e-05 | 187 | 56 | 4 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 8.96e-05 | 187 | 56 | 4 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 9.34e-05 | 189 | 56 | 4 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.53e-05 | 190 | 56 | 4 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.53e-05 | 190 | 56 | 4 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.53e-05 | 190 | 56 | 4 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.53e-05 | 190 | 56 | 4 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.53e-05 | 190 | 56 | 4 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.73e-05 | 191 | 56 | 4 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.73e-05 | 191 | 56 | 4 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | PBMC-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 9.92e-05 | 192 | 56 | 4 | 41a7201febb7d88a39e4ee64df04cce18c691df8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 9.92e-05 | 192 | 56 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 193 | 56 | 4 | b93f6af5999ad207fef5edc2bd900c7c6342f626 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 1.01e-04 | 193 | 56 | 4 | e790ab76c12f74a13936c231076f1e397283efb3 | |
| ToppCell | ILEUM-inflamed-(6)_ILC1|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.03e-04 | 194 | 56 | 4 | dc9ca407ec3ebec1a3dea1213a2beef28c1dc043 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 1.03e-04 | 194 | 56 | 4 | 7773501e076d470158dbc1d7f10c67152b326eb7 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-04 | 194 | 56 | 4 | d2f6c8900b5c448eede8047ca964e94b19bd6ca5 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 1.05e-04 | 195 | 56 | 4 | 789149fb52d9d16393e1649358515add60d37f2d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-04 | 195 | 56 | 4 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 1.05e-04 | 195 | 56 | 4 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-04 | 195 | 56 | 4 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | BL-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.07e-04 | 196 | 56 | 4 | cfbeaabbeeb197f0cf8240a752d1f2995d59d7b7 | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.07e-04 | 196 | 56 | 4 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-04 | 197 | 56 | 4 | 300849a922722adcbc068593fc5cc0bef936d9cb | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-04 | 197 | 56 | 4 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.10e-04 | 197 | 56 | 4 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_2|COVID-19_Mild / Disease condition and Cell class | 1.10e-04 | 197 | 56 | 4 | e844f660010d114d65bd814f3d3fccd8e4a6b8da | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.10e-04 | 197 | 56 | 4 | a97c4a9eb89260b0b5745834ccef9d558d857f93 | |
| ToppCell | COVID-19_Severe-NK_activated|World / disease group, cell group and cell class | 1.10e-04 | 197 | 56 | 4 | a60db36d1a192998e3ded63e0c7c08d41689f95f | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 1.12e-04 | 198 | 56 | 4 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| ToppCell | moderate-Myeloid-Neutrophil|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.12e-04 | 198 | 56 | 4 | a6306dac34af5783f3a734ef1eaa7a0c03267b4f | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 198 | 56 | 4 | ecd93e28bae4152467f6d6621cffc73c301c9795 | |
| Drug | P127-1 | 1.96e-06 | 10 | 59 | 3 | CID000069468 | |
| Drug | mecobalamin | 9.28e-06 | 51 | 59 | 4 | CID006436232 | |
| Drug | glycoluril | 1.08e-05 | 53 | 59 | 4 | CID000062347 | |
| Drug | Gly-His-Lys acetate salt; Down 200; 1uM; MCF7; HT_HG-U133A | 1.10e-05 | 194 | 59 | 6 | 6575_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.23e-05 | 198 | 59 | 6 | 2062_DN | |
| Disease | level of killer cell immunoglobulin-like receptor 2DS2 in blood serum | 1.10e-05 | 3 | 57 | 2 | OBA_2042107 | |
| Disease | cortical thickness | KMT2B C16orf95 CCAR1 POLR2M TMEM131 NCKAP5 ATOH1 PARD3 JMJD1C SLC39A8 | 4.82e-05 | 1113 | 57 | 10 | EFO_0004840 |
| Disease | fornix volume measurement | 7.65e-05 | 7 | 57 | 2 | EFO_0803381 | |
| Disease | white matter microstructure measurement | 1.05e-04 | 390 | 57 | 6 | EFO_0005674 | |
| Disease | gait measurement | 2.06e-04 | 150 | 57 | 4 | EFO_0007680 | |
| Disease | cholesterol to total lipids in IDL percentage | 2.16e-04 | 60 | 57 | 3 | EFO_0022233 | |
| Disease | triglycerides to total lipids in IDL percentage | 2.50e-04 | 63 | 57 | 3 | EFO_0022329 | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 3.79e-04 | 15 | 57 | 2 | EFO_0801746 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 4.32e-04 | 16 | 57 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | brain measurement, neuroimaging measurement | 6.62e-04 | 550 | 57 | 6 | EFO_0004346, EFO_0004464 | |
| Disease | brain age measurement | 6.81e-04 | 20 | 57 | 2 | EFO_0010602 | |
| Disease | prothrombin time measurement | 7.52e-04 | 21 | 57 | 2 | EFO_0008390 | |
| Disease | stomach carcinoma (is_marker_for) | 9.85e-04 | 24 | 57 | 2 | DOID:5517 (is_marker_for) | |
| Disease | neuroimaging measurement | 9.89e-04 | 1069 | 57 | 8 | EFO_0004346 | |
| Disease | inflammatory biomarker measurement | 1.16e-03 | 26 | 57 | 2 | EFO_0004872 | |
| Disease | cortical thickness, neuroimaging measurement | 1.27e-03 | 110 | 57 | 3 | EFO_0004346, EFO_0004840 | |
| Disease | pulmonary hypertension (is_implicated_in) | 1.54e-03 | 30 | 57 | 2 | DOID:6432 (is_implicated_in) | |
| Disease | serum gamma-glutamyl transferase measurement | 1.84e-03 | 914 | 57 | 7 | EFO_0004532 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DRKRHHVLQTAHPSP | 266 | P13051 | |
| SHRGPSERRHHSPSK | 1701 | Q68DN1 | |
| RFFRSHSSPPHHRPG | 21 | Q8NEC5 | |
| HRPEETHKGRTVPAH | 551 | Q8IX12 | |
| RQHRPLPSTPDSSHH | 786 | Q12774 | |
| HNSHARPEPRHLPEK | 141 | Q92560 | |
| SPRRHHNHGSPHLKA | 436 | Q9UK58 | |
| CAPHPAPRSRHHLKG | 356 | O94850 | |
| RSHEPEAIHIPHRKP | 296 | Q969G9 | |
| TDRAARKEHHSPHGP | 321 | Q86UN2 | |
| RKEHHSPHGPTRSKG | 326 | Q86UN2 | |
| HTQKAHRDRTPHGAP | 316 | Q9HBI0 | |
| QRADPPKAHVAHHPI | 201 | P30511 | |
| PHEGVHRKPSLLAHP | 21 | P43631 | |
| EPPKTRGSRGHLHTH | 61 | Q9H607 | |
| PRSLSPAHKHHSQAL | 336 | Q8N109 | |
| HLCPEPPKTRVSHLH | 281 | Q5HY64 | |
| CRHHAPSPPRPEHAS | 461 | Q8N612 | |
| PPSSAHRSHLKHRHP | 656 | P23352 | |
| SSPTSPERPRHHHHD | 216 | Q9BU76 | |
| PHEGVHRKPSLLAHP | 21 | P43627 | |
| PHEGVHRKPSLLAHP | 21 | P43628 | |
| APVFHPPIHHSLERK | 1206 | Q15652 | |
| RRTAPEIHHRKPHGP | 911 | Q13191 | |
| PRSLSPAHKHHSQAL | 336 | Q8NHK3 | |
| NGKHRVTHLPSPHPK | 351 | A0A1B0GTH6 | |
| LDPAHKSHFHPVTPS | 111 | Q6P2I7 | |
| AHTPRRSLPSHHGKK | 946 | Q9UMN6 | |
| RHPHAIPGSILSHKT | 536 | Q96M63 | |
| HRHGSPHPSRRTAPA | 326 | Q96GM1 | |
| RAHPRVPSHSDSHPK | 856 | Q4ZHG4 | |
| PPPASCKSDHHHLRT | 226 | Q92858 | |
| LGRPASESPHHHTAP | 56 | P35520 | |
| PEHSKHRSASPEHPQ | 246 | Q96PX6 | |
| SHPHPEHPKTRRRSS | 476 | Q5JRC9 | |
| SPPSPRRCHHHHEAT | 6 | Q9H693 | |
| RKPHTAHSSRAPRSP | 1021 | Q9C0E4 | |
| RVPPSSEASEHHPRH | 161 | P0CAP2 | |
| PRTSLPHFHHPETSR | 121 | Q08495 | |
| PHEGVHRKPSLLAHP | 21 | P43626 | |
| SDPHPSHPDQRAHFR | 466 | O75807 | |
| DSHSRLPHSAHPSGK | 416 | Q8TEW0 | |
| PHEGVHRKPSLLAHP | 21 | Q14954 | |
| LVHRKGSTRAFPPHH | 371 | Q9Y3I0 | |
| HTAATHPPRPRHLMD | 1271 | A6NKG5 | |
| KHTHHAPLSPRTFHP | 1036 | P12259 | |
| SDPHIPKHSAQLPHS | 861 | O14513 | |
| PPAHSPVHSHLSLER | 1681 | O60292 | |
| SPSPIHPAHHKRDRR | 876 | P08514 | |
| QPPSRHVPHEKLQSH | 341 | Q8NA69 | |
| KREHTHPSMHRDGPP | 1311 | Q07889 | |
| RPSPHSKLHKGTALH | 326 | O00506 | |
| HHRSKTPRHLDPSLA | 101 | O43463 | |
| FHGIHLPRRSPVHSK | 291 | Q86XI2 | |
| SPVERPPRAGHSEHH | 1216 | O94966 | |
| RHEHSPHPQSRTGTP | 411 | Q92738 | |
| ASHAPDHTRHLDPGK | 506 | P21580 | |
| PLHPMSEIPRRSHHS | 231 | Q9NVW2 | |
| LAHPSHPERASSARH | 1326 | Q92545 | |
| AGRPHHDQRSSSPHL | 1171 | Q6IQ55 | |
| DKPTHPRAREHSASP | 146 | Q6ZMY9 | |
| PNTKCHSPERAHHRS | 666 | Q9BZW7 | |
| SAVKPDRAATPHHRP | 131 | P49765 | |
| HPCEDRPKHKTRPSH | 111 | Q9C0K1 | |
| SHPHRPRASHRTPAA | 1231 | O15399 | |
| PRASHRTPAAAAPHH | 1236 | O15399 |